BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22167350)

  • 1. Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles.
    Liu Q; Shen Y; Chen J; Gao X; Feng C; Wang L; Zhang Q; Jiang X
    Pharm Res; 2012 Feb; 29(2):546-58. PubMed ID: 22167350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of wheat germ agglutinin density on cellular uptake and toxicity of wheat germ agglutinin conjugated PEG-PLA nanoparticles in Calu-3 cells.
    Shen Y; Chen J; Liu Q; Feng C; Gao X; Wang L; Zhang Q; Jiang X
    Int J Pharm; 2011 Jul; 413(1-2):184-93. PubMed ID: 21550388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain.
    Liu Q; Shao X; Chen J; Shen Y; Feng C; Gao X; Zhao Y; Li J; Zhang Q; Jiang X
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):79-84. PubMed ID: 21163285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
    Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
    Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of transcellular transport of wheat germ agglutinin-functionalized polymeric nanoparticles in Caco-2 cells.
    Song Q; Yao L; Huang M; Hu Q; Lu Q; Wu B; Qi H; Rong Z; Jiang X; Gao X; Chen J; Chen H
    Biomaterials; 2012 Oct; 33(28):6769-82. PubMed ID: 22705199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.
    Xia H; Gao X; Gu G; Liu Z; Zeng N; Hu Q; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H
    Biomaterials; 2011 Dec; 32(36):9888-98. PubMed ID: 21937105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
    Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
    J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UEA I-bearing nanoparticles for brain delivery following intranasal administration.
    Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X
    Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of molecules from nose to brain: transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium.
    Shipley MT
    Brain Res Bull; 1985 Aug; 15(2):129-42. PubMed ID: 3840049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.
    Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X
    J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
    Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
    Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
    Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
    Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.
    Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L
    Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal delivery of α-asarone to the brain with lactoferrin-modified mPEG-PLA nanoparticles prepared by premix membrane emulsification.
    Pan L; Zhou J; Ju F; Zhu H
    Drug Deliv Transl Res; 2018 Feb; 8(1):83-96. PubMed ID: 29134552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocytic and exocytic pathways of the neuronal secretory process and trans-synaptic transfer of wheat germ agglutinin-horseradish peroxidase in vivo.
    Broadwell RD; Balin BJ
    J Comp Neurol; 1985 Dec; 242(4):632-50. PubMed ID: 2418083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats.
    Zhang QZ; Zha LS; Zhang Y; Jiang WM; Lu W; Shi ZQ; Jiang XG; Fu SK
    J Drug Target; 2006 Jun; 14(5):281-90. PubMed ID: 16882548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modification by wheat germ agglutinin delays the ocular elimination of liposome].
    Zhang WJ; Yang DX; Feng LL; Wang F; Wei G; Lu WY
    Yao Xue Xue Bao; 2014 Apr; 49(4):543-9. PubMed ID: 24974475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
    Sheng Y; He H; Zou H
    Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of in vivo olfactory uptake and transfer using fluorescein dextran.
    Jansson B; Björk E
    J Drug Target; 2002 Aug; 10(5):379-86. PubMed ID: 12442808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.